Neurofibromatosis Research at MGH NF Clinic Referrals | NF Clinic Staff | NeuroGenetic Surgery | Guestbook | NF Research | NF Links

References for NF2 Mutation Maps:

1. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, et al. 1993. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800.

2. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, et al. 1993. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521.

3. MacCollin M, Mohney T, Trofatter J, Wertelecki W, Ramesh V, Gusella J. 1993. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree JAMA 270:2316-2320.

4. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V, et al. 1994. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413-419.

5. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA. 1994. The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151.

6. MacCollin M, Ramesh V, Jacoby LB, Louis DN, Rubio MP, Pulaski K, Trofatter JA, Short MP, Bove C, Eldridge R, et al. 1994. Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 55:314-320.

7. Bourn D, Carter SA, Mason S, Gareth D, Evans R, Strachan T. 1994. Germline mutations in the neurofibromatosis type 2 tumour suppressor gene. Hum Mol Genet 3:813-816.

8. Sainz J, Figueroa K, Baser ME, Mautner VF, Pulst SM. 1995. High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA codons. Hum Mol Genet. 4:137-139.

9. Merel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, et al. 1995. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer 13:211-216.

10. Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJ. 1994. Analysis of mutations in the SCH gene in schwannomas. Genes Chromosomes Cancer. 11:7-14.

11. Honda M, Arai E, Sawada S, Ohta A, Niimura M. 1995. Neurofibromatosis 2 and neurilemmomatosis gene are identical. J Invest Dermatol. 104:74-77.

12. Bourn D, Evans G, Mason S, Tekes S, Trueman L, Strachan T. 1995. Eleven novel mutations in the NF2 tumour suppressor gene. Hum Genet 95:572-574.

13. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM 1994. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet. 3:885-891.

14. Scoles DR, Baser ME, Pulst SM. 1996. A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes. Neurology 47:544-546.

15. Ruttledge MH, Andermann AA, Phelan CM, Claudio JO, Han FY, Chretien N, Rangaratnam S, MacCollin M, Short P, Parry D, Michels V, Riccardi VM, Weksberg R, Kitamura K, Bradburn JM, Hall BD, Propping P, Rouleau GA. 1996. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59:331-342.

16. Parry DM, MacCollin MM, Kaiser-Kupfer MI, Pulaski K, Nicholson HS, Bolesta M, Eldridge R, Gusella JF. 1996. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 59:529-539.

17. Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF. 1996. Frequency and distribution of NF2 mutations in schwannomas. Genes Chromsomes Cancer 17:45-55.

18. MacCollin M, Braverman N, Viskochil D, Ruttledge M, Davis K, Ojemann R, Gusella J, Parry DM. 1996. A point mutation associated with a severe phenotype of neurofibromatosis 2. Ann Neurol. 40:440-445.

19. Kluwe L, Bayer S, Baser ME, Hazim W, Haase W, Funsterer C, Mautner VF. 1996. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes. Hum Genet 98:534-538.

20. Kluwe L, MacCollin M, Tatagiba M, Thomas S, Hazim W, Haase W, Mautner VF.1998. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene. Am J Med Genet 77:228-233.

21. Evans DG, Trueman L, Wallace A, Collins S, Strachan T. 1998. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 35:450-455.

22. Jacoby LB, MacCollin M, Parry DM, Kluwe L, Lynch J, Jones D, Gusella JF. 1999. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis. Neurogenetics 2:101-108.

23. Kluwe L, Mautner V, Parry DM, Jacoby LB, Baser M, Gusella J, Davis K, Stavrou D, MacCollin M. 2000. The parental origin of new mutations in neurofibromatosis 2. Neurogenetics 3:17-24.

24. Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, MacCollin M. 1997.
Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 61:1293-1302.

25. Zucman-Rossi J, Legoix P, Der Sarkissian H, Cheret G, Sor F, Bernardi A, Cazes L, Giraud S, Ollagnon E, Lenoir G, Thomas G. 1998. NF2 gene in neurofibromatosis type 2 patients. Hum Mol Genet 7:2095-2101.

26. Kluwe L, Mautner VF. 1998. Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet 7:2051-2055.

27. De Klein A, Riegman PH, Bijlsma EK, Heldoorn A, Muijtjens M, den Bakker MA, Avezaat CJ, Zwarthoff EC. 1998. G>A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2. Hum Mol Genet 7:393-398.

28. Chen HJ, Teng HC, Li SS. 1998. Molecular characterization of germline mutations in neurofibromatosis 2 in two families. J Formos Med Assoc 97:869-872.

29. Harada H, Kumon Y, Hatta N, Sakaki S, Ohta S. 1999. Neurofibromatosis type 2 with multiple primary brain tumors in monozygotic twins. Surg Neurol 51:528-535.

30. Hung G, Faudoa R, Baser ME, Xue Z, Kluwe L, Slattery W, Brackman D, Lim D. 2000. Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas. Cancer Genet Cytogenet 118:167-168 and Faudoa R, Xue Z, Lee F, Baser ME, Hung G. 2000. Detection of novel NF2 mutations by an RNA mismatch cleavage method. Hum Mutat. 15:474-478. (Note: both papers published the same mutations).

31. Sestini R, Vivarelli R, Balestri P, Ammannati F, Montali E, Papi L. 2000. Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene. Hum Genet 107:366-371.

32. Sainio M, Jaaskelainen J, Pihlaja , Carpen O. 2000. Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus. Neurology 54:1132-1138.

33. Kluwe L, Friedrich RE, Hagel C, Lindenau M, Mautner VF. 2000. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors. J Invest Dermatol. 114:1017-1021.

34. Lamszus K, Vahldiek F, Mautner VF, Schichor C, Tonn J, Stavrou D, Fillbrandt R, Westphal M, Kluwe L. 2000. Allelic losses in neurofibromatosis 2-associated meningiomas. J Neuropathol Exp Neurol 59:504-512.

35. Kehrer-Sawatzki H, Udart M, Krone W, Baden R, Fahsold R, Thomas G, Schmucker B, Assum G. 1997. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2. Hum Genet 100:67-74.

36. Hagel C, Lindenau M, Lamszus K, Kluwe L, Stavrou D, Mautner VF. 2002. Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol 104:179-187.

37. Kluwe L, Mautner V, Heinrich B, Dezube R, Jacoby LB, Friedrich RE, MacCollin M. 2003. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40:109-114.

38. Baser ME, Kluwe L, Mautner VF. 1999. Germ-line NF2 mutations and disease severity in neurofibromatosis type 2 patients with retinal abnormalities. Am J Hum Genet 64:1230-3.

39. Kaufman DL, Heinrich BS, Willett C, Perry A, Finseth F, Sobel RA, MacCollin M. 2003. Somatic instability of the NF2 gene in schwannomatosis. Arch Neurol 60:1317-1320.

40. MacCollin M, Willett C, Heinrich B, Jacoby LB, Acierno JS Jr, Perry A, Louis DN. 2003. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology 60:1968-1974.

41. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. 1994. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 3:347-50.

42. Merel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, et al. 1995. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer 13:211-216.

43. Lasota J, Fetsch JF, Wozniak A, Wasag B, Sciot R, Miettinen M. 2001. The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases. Am J Pathol 158:1223-1229.

44. Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD. 1995. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55:1227-1231.

45. Leone PE, Bello MJ, Mendiola M, Vaquero J, Sarasa JL, Kusak ME, De Campos JM, Pestana A, Rey JA. 1998. Six novel mutations in the NF2 tumor suppressor gene. Int J Oncol 12:935-938.

46. Cheng JQ, Lee WC, Klein MA, Cheng GZ, Jhanwar SC, Testa JR. 1999. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation.Genes Chromosomes Cancer 24:238-242.

47. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, et al. 1994. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet. 6:180-4.
48. Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A. 1995. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.Am J Pathol 146:827-832.

49. de Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bigozzi U, Montali E, Papi L. 1996. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum Genet 97:632-637.

50. Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T. 1999. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Cancer Res 59:5995-5998.

51. Leone PE, Bello MJ, de Campos JM, Vaquero J, Sarasa JL, Pestana A, Rey JA. 1999. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene. 18:2231-2239.

52. Mohyuddin A, Neary WJ, Wallace A, Wu CL, Purcell S, Reid H, Ramsden RT, Read A, Black G, Evans DG. 2002. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas. J Med Genet 39:315-322.

53. Welling DB, Guida M, Goll F, Pearl DK, Glasscock ME, Pappas DG, Linthicum FH, Rogers D, Prior TW. 1996. Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas. Hum Genet 98:189-193.

54. Stangl AP, Wellenreuther R, Lenartz D, Kraus JA, Menon AG, Schramm J, Wiestler OD, von Deimling A. 1997. Clonality of multiple meningiomas. J Neurosurg 86:853-858.

55. Heinrich B, Hartmann C, Stemmer-Rachamimov AO, Louis DN, MacCollin M. 2003. Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms. Int J Cancer 103:483-488.

56. Eckstein O, Stemmer-Rachamimov A, Nunes F, Hoch D, Ojemann R, MacCollin M. 2004. Multiple meningiomas in brain and lung due to acquired mutation of the NF2 gene. Neurology 62:1904-1905.

57. Kambe A, Kamitani H, Watanabe T, Oka A, Inagaki H, Ishii T, Ueki K. 2005. non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report. Surg Neurol. 63:62-65.

58. Evans DG, Watson C, King A, Wallace AJ, Baser ME. 2005. Multiple meningiomas: differential involvement of the NF2 gene in children and adults. J Med Genet 42:45-48.

59. Lomas J, Bello MJ, Arjona D, Alonso ME, Martinez-Glez V, Lopez-Marin I, Aminoso C, de Campos JM, Isla A, Vaquero J, Rey JA. 2005. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas. Genes Chromosomes Cancer 42:314-319.

60. Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN. 1996. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery 39:135-140.

61. Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN. 1994. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54:45-47.

62. Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A. 1999. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Am J Pathol 155:627-632.

63. Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Hoppner W, Stavrou D, Fillbrandt R, Westphal M. 2001. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Int J Cancer 91:803-808.

64. Alonso ME, Bello MJ, Arjona D, Gonzalez-Gomez P, Lomas J, de Campos JM, Kusak ME, Isla A, Rey JA. 2002. Analysis of the NF2 gene in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 134:1-5.

65. Wallace AJ, Watson CJ, Oward E, Evans DG, Elles RG. 2004. Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis. Genet Test 8:368-380.

66. Aghi M, Kluwe L, Webster MT, Jacoby LB, Barker FG, Ojemann RG, Mautner V-F, MacCollin M. Unilateral vestibular schwannoma with other neurofibromatosis Type 2-related tumors: clinical and molecular study of a unique phenotype. Journal of Neurosurgery 104: 201-207. 2006.

67. Tsilchorozidou T, Menko FH, Lalloo F, Kidd A, De Silva R, Thomas H, Smith P, Malcolmson A, Dore J, Madan K, Brown A, Yovos JG, Tsaligopoulos M, Vogiatzis N, Baser ME, Wallace AJ, Evans DG. 2004. Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2.J Med Genet 41:529-534.

68. Szijan I, Rochefort D, Bruder C, Surace E, Machiavelli G, Dalamon V, Cotignola J, Ferreiro V, Campero A, Basso A, Dumanski JP, Rouleau GA. 2003. NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH. Neuromolecular Med 3:41-52.

69. Kluwe L, Nygren AO, Errami A, Heinrich B, Matthies C, Tatagiba M, Mautner V. 2005. Screening for large mutations of the NF2 gene. Genes Chromosomes Cancer 42:384-391.

70. Legoix P, Sarkissian HD, Cazes L, Giraud S, Sor F, Rouleau GA, Lenoir G, Thomas G, Zucman-Rossi J. 2000. Molecular characterization of germline NF2 gene rearrangements. Genomics 65:62-66.

71. Bruder CE, Hirvela C, Tapia-Paez I, Fransson I, Segraves R, Hamilton G, Zhang XX, Evans DG, Wallace AJ, Baser ME, Zucman-Rossi J, Hergersberg M, Boltshauser E, Papi L, Rouleau GA, Poptodorov G, Jordanova A, Rask-Andersen H, Kluwe L, Mautner V, Sainio M, Hung G, Mathiesen T, Moller C, Pulst SM, Harder H, Heiberg A, Honda M, Niimura M, Sahlen S, Blennow E, Albertson DG, Pinkel D, Dumanski JP. 2001. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet 10:271-282.

72. Watson CJ, Gaunt L, Evans G, Patel K, Harris R, Strachan T. 1993. A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus. Hum Mol Genet 2:701-4.

73. Sanson M, Marineau C, Desmaze C, Lutchman M, Ruttledge M, Baron C, Narod S, Delattre O, Lenoir G, Thomas G, et al. 1993. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Hum Mol Genet 2:1215-1220.

74. Diaz de Stahl T, Hansson CM, Bustos C, Mantripragada KK, Piotrowski A, Benetkiewicz M, Jarbo C, Wiklund L, Mathiesen T, Nyberg G, Collins VP, Evans DG, Ichimura K, Dumanski JP. 2005. High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas. Hum Genet 118:35-44.

75. Bian LG, Tirakotai W, Sun QF, Zhao WG, Shen JK, Luo QZ. 2005. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China. J Neurooncol 73:253-260.

76. Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O, Platania N, Gabriele AL, Albanese V, Pavone L. 2005. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics 36:21-34.

77. Ikeda T, Hashimoto S, Fukushige S, Ohmori H, Horii A. 2005. Comparative genomic hybridization and mutation analyses of sporadic schwannomas. J Neurooncol 72:225-230.

78. Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS, Huang DP. 1995. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery 37:764-773.

79. Joachim T, Ram Z, Rappaport ZH, Simon M, Schramm J, Wiestler OD, von Deimling A. 2001. Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas. Int J Cancer 94:218-221.

80. Bijlsma EK, Wallace AJ, Evans DG. 1997. Misleading linkage results in an NF2 presymptomatic test owing to mosaicism. J Med Genet 34:934-936.

81. Evans JJ, Jeun SS, Lee JH, Harwalkar JA, Shoshan Y, Cowell JK, Golubic M. 2001. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas. J Neurosurg 94:111-117.

82. Mohyuddin A, Neary WJ, Wallace A, Wu CL, Purcell S, Reid H, Ramsden RT, Read A, Black G, Evans DG. 2002. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas. J Med Genet 39:315-322.

83. Schipper H, Papp T, Johnen G, Pemsel H, Bastrop R, Muller KM, Wiethege T, Jaworska M, Krismann M, Schiffmann D, Rahman Q. 2003. Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
Int J Oncol 22:1009-1017.

84. Kazakov DV, Pitha J, Sima R, Vanecek T, Shelekhova K, Mukensnabl P, Michal M. 2005. Hybrid peripheral nerve sheath tumors: Schwannoma-perineurioma and neurofibroma-perineurioma. A report of three cases in extradigital locations.
Ann Diagn Pathol 9:16-23.

85. Zhu JJ, Maruyama T, Jacoby LB, Herman JG, Gusella JF, Black PM, Wu JK. 1999. Clonal analysis of a case of multiple meningiomas using multiple molecular genetic approaches: pathology case report. Neurosurgery 45:409-416.

86. Kluwe L, Friedrich RE, Tatagiba M, Mautner VF. 2002. Presymptomatic diagnosis for children of sporadic neurofibromatosis 2 patients: a method based on tumor analysis. Genet Med 4:27-30.

87. Mautner VF, Baser ME, Thakkar SD, Feigen UM, Friedman JM, Kluwe L. 2002. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study. J Neurosurg 96:223-228.

88. Leverkus M, Kluwe L, Roll EM, Becker G, Brocker EB, Mautner VF, Hamm H. 2003. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis? Br J Dermatol 148:804-809.

89. Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U. 1995. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95:347-351.

90. von Deimling A, Kraus JA, Stangl AP, Wellenreuther R, Lenartz D, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD. 1995. Evidence for subarachnoid spread in the development of multiple meningiomas. Brain Pathol. 1995 Jan;5(1):11-14.

91. Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJ, Testa JR. 1995. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci USA 92:10854-10858.

92. Irving RM, Harada T, Moffat DA, Hardy DG, Whittaker JL, Xuereb JH, Maher ER. 1997. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma. Am J Otol 18:754-760.

93. Sestini R, Putignano AL, Ammannati F, Papi L. 2005. Detection of rearrangements in the NF2 gene using semi-quantitative multiplex fluorescent PCR. Genet Test 9:14-19.

U. MacCollin et al., unpublished observations

Mia MacCollin, M.D.
html Editor

Clinic Referrals | NF Clinic Staff NeuroGenetic Surgery | Guestbook NF Research | Links